| Bos taurus |
Cyclooxygenase-1 |
IC50 |
100000.0 |
nM |
10.1021/np970343j |
| Bos taurus |
Cyclooxygenase-1 |
Inhibition |
9.0 |
% |
10.1021/np970343j |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Arachidonate 5-lipoxygenase |
IC50 |
10000.0 |
nM |
10.1016/s0960-894x(02)00013-6 |
| Homo sapiens |
Cyclooxygenase |
Ratio |
3600.0 |
None |
10.1021/jm9906015 |
| Homo sapiens |
Cyclooxygenase |
Selectivity |
1000.0 |
None |
10.1016/0960-894X(95)00131-C |
| Homo sapiens |
Cyclooxygenase |
Selectivity |
1000.0 |
None |
10.1021/jm00022a023 |
| Homo sapiens |
Cyclooxygenase |
Selectivity |
1000.0 |
None |
10.1021/jm00049a005 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
3000.0 |
nM |
10.1016/s0960-894x(02)00013-6 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
3300.0 |
nM |
10.1021/jm9805081 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
3300.0 |
nM |
10.1021/jm980570y |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
10000.0 |
nM |
10.1021/jm00049a005 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
35680.0 |
nM |
10.1016/j.bmc.2007.11.033 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
100000.0 |
nM |
10.1016/0960-894X(95)00131-C |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
100000.0 |
nM |
10.1021/jm00022a023 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
100000.0 |
nM |
10.1021/np980088i |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
220000.0 |
nM |
10.1016/j.bmcl.2014.10.031 |
| Homo sapiens |
Cyclooxygenase-1 |
Selectivity |
1000.0 |
None |
10.1016/s0960-894x(02)00013-6 |
| Homo sapiens |
Cyclooxygenase-2 |
Activity |
nan |
None |
10.1021/jm051126f |
| Homo sapiens |
Cyclooxygenase-2 |
Activity |
nan |
None |
10.1021/np049655u |
| Homo sapiens |
Cyclooxygenase-2 |
ED50 |
4.7 |
mg.kg-1 |
10.1021/jm00049a005 |
| Homo sapiens |
Cyclooxygenase-2 |
FC |
5.29 |
None |
10.1038/nchembio.147 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1.0 |
nM |
10.1016/s0960-894x(02)00013-6 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
10.0 |
nM |
10.1021/jm00049a005 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
90.0 |
nM |
10.1016/s0960-894x(98)00717-3 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
100.0 |
nM |
10.1016/0960-894X(95)00131-C |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
100.0 |
nM |
10.1021/jm00022a023 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
120.0 |
nM |
10.1016/s0960-894x(01)00792-2 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
150.0 |
nM |
10.1021/np100057y |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
160.0 |
nM |
10.1021/np020023m |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
160.0 |
nM |
10.1021/np049655u |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
190.0 |
nM |
10.1021/jm9805081 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
190.0 |
nM |
10.1021/jm980570y |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
260.0 |
nM |
10.1016/j.ejmech.2018.11.027 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
610.0 |
nM |
10.1016/j.bmc.2007.11.033 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1000.0 |
nM |
10.1016/j.ejmech.2012.08.046 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1800.0 |
nM |
10.1016/j.bmcl.2014.02.074 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1800.0 |
nM |
10.1016/j.bmcl.2014.10.031 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1800.0 |
nM |
10.1016/j.bmcl.2016.09.070 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
2100.0 |
nM |
10.1016/j.ejmech.2014.03.001 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
2100.0 |
nM |
10.1016/j.ejmech.2018.11.027 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
2200.0 |
nM |
10.1016/j.bmc.2015.03.049 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
3200.0 |
nM |
10.1016/s0960-894x(98)00179-6 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
28000.0 |
nM |
10.1021/jm701575k |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
53000.0 |
nM |
10.1021/np980088i |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
85.3 |
% |
10.1016/j.tet.2008.04.022 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
85.3 |
% |
10.1021/np800014s |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
91.1 |
% |
10.1016/j.ejmech.2010.02.012 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
97.09 |
% |
10.1021/np900374s |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
97.1 |
% |
10.1016/j.ejmech.2021.113165 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
nan |
% |
10.1016/j.bmc.2011.06.069 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.10.051 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
nan |
% |
10.1038/nchembio.147 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
680.0 |
nM |
10.1021/jm051126f |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
680.0 |
nM |
10.1021/jm701107h |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
nan |
% |
10.1021/jm051126f |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
3981.07 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
79.43 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
79.4 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
50.12 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
50.1 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
19952.62 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
HaCaT |
IC50 |
10.0 |
nM |
10.1021/np049873n |
| Homo sapiens |
HaCaT |
Inhibition |
93.8 |
% |
10.1021/np049873n |
| Homo sapiens |
HaCaT |
Inhibition |
nan |
% |
10.1021/np049873n |
| Homo sapiens |
Homo sapiens |
IC50 |
6800.0 |
nM |
10.1021/jm9906015 |
| Homo sapiens |
HUVEC |
Inhibition |
nan |
% |
10.1021/np300446c |
| Homo sapiens |
MDA-MB-231 |
Activity |
nan |
None |
10.1021/jm051126f |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Prostaglandin E synthase |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2011.12.009 |
| Homo sapiens |
Prostaglandin E synthase |
IC50 |
20000.0 |
nM |
10.1016/j.bmc.2011.08.040 |
| Homo sapiens |
Prostaglandin E synthase |
IC50 |
20000.0 |
nM |
10.1016/j.bmcl.2012.10.085 |
| Homo sapiens |
Prostaglandin E synthase |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2011.12.009 |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
SK-BR-3 |
Activity |
nan |
None |
10.1021/jm051126f |
| Homo sapiens |
SK-BR-3 |
IC50 |
720.0 |
nM |
10.1016/j.bmcl.2006.10.065 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
26608.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
44668.4 |
nM |
None |
| Mus musculus |
Cyclooxygenase-1 |
IC50 |
1670.0 |
nM |
10.1016/j.bmcl.2004.02.099 |
| Mus musculus |
Cyclooxygenase-1 |
IC50 |
63700.0 |
nM |
10.1016/j.bmc.2009.12.008 |
| Mus musculus |
Cyclooxygenase-2 |
Activity |
8.5 |
(ng of PGE2) (mg of protein)-1 |
10.1021/jm991085l |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
2.0 |
nM |
10.1016/j.bmcl.2004.02.099 |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
7.0 |
nM |
10.1016/j.bmcl.2014.02.074 |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
22.0 |
nM |
10.1021/jm9805081 |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
22.0 |
nM |
10.1021/jm980570y |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
50.0 |
nM |
10.1016/j.bmcl.2009.02.001 |
| Mus musculus |
Cyclooxygenase-2 |
IC50 |
810.0 |
nM |
10.1016/j.bmc.2009.12.008 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
11.0 |
% |
10.1016/j.ejmech.2018.01.054 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
61.0 |
% |
10.1016/j.ejmech.2018.01.054 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
88.0 |
% |
10.1016/j.ejmech.2018.01.054 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
94.0 |
% |
10.1016/j.ejmech.2018.01.054 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
98.3 |
% |
10.1016/j.bmcl.2003.12.087 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
99.3 |
% |
10.1016/j.bmcl.2008.11.017 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
100.0 |
% |
10.1016/j.bmcl.2010.05.092 |
| Mus musculus |
Cyclooxygenase-2 |
Inhibition |
109.0 |
% |
10.1016/j.bmcl.2009.02.001 |
| Mus musculus |
Lewis lung carcinoma cell line |
Activity |
22.0 |
% |
10.1021/np300446c |
| Mus musculus |
Lewis lung carcinoma cell line |
TGI |
42.0 |
% |
10.1021/np300446c |
| Mus musculus |
Mus musculus |
ED40 |
7.4 |
mg kg-1 |
10.1021/jm9805081 |
| Mus musculus |
Mus musculus |
Edema |
97.2 |
ul |
10.1021/jm000997g |
| Mus musculus |
Mus musculus |
IC50 |
2.1 |
nM |
10.1021/jm000997g |
| Mus musculus |
Mus musculus |
IC50 |
3100.0 |
nM |
10.1021/jm991085l |
| Mus musculus |
Mus musculus |
PGE2 Level |
2.1 |
ng ml-1 |
10.1021/jm000997g |
| Mus musculus |
Mus musculus |
PGE2 Level |
3.7 |
ng ml-1 |
10.1021/jm000997g |
| Mus musculus |
Mus musculus |
PGE2 Level |
53.0 |
ng ml-1 |
10.1021/jm000997g |
| Mus musculus |
Prostaglandin E synthase |
IC50 |
7.0 |
nM |
10.1016/j.bmcl.2016.09.070 |
| Mus musculus |
Prostaglandin E synthase |
Inhibition |
86.0 |
% |
10.1016/j.bmcl.2016.09.070 |
| Mus musculus |
RAW264.7 |
Activity |
0.07 |
ng/ml |
10.1021/jm0700823 |
| Mus musculus |
RAW264.7 |
Activity |
3.2 |
ng/ml |
10.1016/j.bmcl.2009.05.070 |
| Mus musculus |
RAW264.7 |
Activity |
3.7 |
ng/ml |
10.1021/np0101898 |
| Mus musculus |
RAW264.7 |
Activity |
12.02 |
ng/ml |
10.1016/j.ejmech.2019.111955 |
| Mus musculus |
RAW264.7 |
Activity |
100.0 |
% |
10.1016/j.bmcl.2014.06.061 |
| Mus musculus |
RAW264.7 |
Activity |
104.0 |
% |
10.1016/j.bmcl.2009.02.001 |
| Mus musculus |
RAW264.7 |
Activity |
nan |
None |
10.1021/jm0700823 |
| Mus musculus |
RAW264.7 |
Activity |
nan |
None |
10.1021/np0101898 |
| Mus musculus |
RAW264.7 |
IC50 |
6.7 |
nM |
10.1021/acs.jnatprod.9b00697 |
| Mus musculus |
RAW264.7 |
IC50 |
7.0 |
nM |
10.1016/j.bmcl.2014.10.031 |
| Mus musculus |
RAW264.7 |
IC50 |
7.0 |
nM |
10.1016/j.bmcl.2015.11.024 |
| Mus musculus |
RAW264.7 |
IC50 |
7.01 |
nM |
10.1016/j.bmcl.2013.12.018 |
| Mus musculus |
RAW264.7 |
IC50 |
7.23 |
nM |
10.1016/j.bmcl.2017.10.035 |
| Mus musculus |
RAW264.7 |
IC50 |
7.23 |
nM |
10.1016/j.ejmech.2017.10.003 |
| Mus musculus |
RAW264.7 |
IC50 |
100.0 |
nM |
10.1016/j.bmcl.2014.06.061 |
| Mus musculus |
RAW264.7 |
IC50 |
500.0 |
nM |
10.1016/j.bmcl.2003.12.087 |
| Mus musculus |
RAW264.7 |
IC50 |
2100.0 |
nM |
10.1021/np0101898 |
| Mus musculus |
RAW264.7 |
IC50 |
4800.0 |
nM |
10.1016/j.bmcl.2009.11.067 |
| Mus musculus |
RAW264.7 |
IC50 |
6740.0 |
nM |
10.1016/j.bmcl.2017.03.057 |
| Mus musculus |
RAW264.7 |
IC50 |
10000.0 |
nM |
10.1021/np0101898 |
| Mus musculus |
RAW264.7 |
IC50 |
nan |
None |
10.1016/j.ejmech.2017.10.003 |
| Mus musculus |
RAW264.7 |
IC80 |
nan |
None |
10.1016/j.ejmech.2017.10.003 |
| Mus musculus |
RAW264.7 |
Inhibition |
58.0 |
% |
10.1016/j.ejmech.2019.07.030 |
| Mus musculus |
RAW264.7 |
Inhibition |
59.5 |
% |
10.1016/j.bmcl.2019.126884 |
| Mus musculus |
RAW264.7 |
Inhibition |
97.0 |
% |
10.1016/j.bmcl.2014.06.061 |
| Mus musculus |
RAW264.7 |
Inhibition |
99.42 |
% |
10.1016/j.bmcl.2014.10.031 |
| Mus musculus |
RAW264.7 |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.11.016 |
| Mus musculus |
RAW264.7 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2013.12.018 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
14100.0 |
nM |
10.1021/jm100398z |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
20000.0 |
nM |
10.1021/jm9805081 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
20000.0 |
nM |
10.1021/jm980570y |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
37000.0 |
nM |
10.1016/s0960-894x(98)00717-3 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
66000.0 |
nM |
10.1016/s0960-894x(01)00792-2 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
205400.0 |
nM |
10.1016/j.ejmech.2012.08.046 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
213000.0 |
nM |
10.1016/j.bmc.2015.03.049 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
213200.0 |
nM |
10.1016/j.ejmech.2014.03.001 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
220000.0 |
nM |
10.1016/j.bmcl.2014.02.074 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
220000.0 |
nM |
10.1016/j.bmcl.2016.09.070 |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
2100.0 |
nM |
10.1021/np200343t |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
2600.0 |
nM |
10.1016/j.bmc.2009.05.018 |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
2600.0 |
nM |
10.1016/j.bmc.2009.10.031 |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
53000.0 |
nM |
10.1021/np970343j |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
73200.0 |
nM |
10.1021/jm100398z |
| Ovis aries |
Cyclooxygenase-2 |
Inhibition |
45.06 |
% |
10.1016/j.ejmech.2015.07.003 |
| Rattus norvegicus |
Cyclooxygenase-1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2015.07.003 |
| Rattus norvegicus |
Rattus norvegicus |
Damaged area |
0.0 |
% |
10.1021/jm980570y |
| Rattus norvegicus |
Rattus norvegicus |
ED40 |
0.61 |
mg kg-1 |
10.1021/jm9805081 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.61 |
mg.kg-1 |
10.1021/jm980570y |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.0 |
mg.kg-1 |
10.1021/jm9906015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
4.7 |
mg.kg-1 |
10.1016/0960-894X(95)00131-C |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
7.4 |
mg.kg-1 |
10.1021/jm980570y |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
30.0 |
mg.kg-1 |
10.1021/jm9906015 |
| Rattus norvegicus |
Rattus norvegicus |
Gastric damage |
0.0 |
% |
10.1021/jm9805081 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
30.7 |
% |
10.1021/jm9805081 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
30.7 |
% |
10.1021/jm980570y |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
60.0 |
% |
10.1016/0960-894X(95)00131-C |
| Rattus norvegicus |
Rattus norvegicus |
Lesion frequency |
0.0 |
% |
10.1021/jm9805081 |
| Rattus norvegicus |
Rattus norvegicus |
Lesion frequency |
0.0 |
% |
10.1021/jm980570y |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.83 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.5 |
% |
10.6019/CHEMBL4495565 |
| None |
Neutrophil |
Inhibition |
nan |
% |
10.1021/np049873n |
| None |
No relevant target |
LogP |
nan |
None |
10.1016/0960-894X(95)00131-C |
| None |
PBL |
Inhibition |
nan |
% |
10.1016/j.ejmech.2012.09.005 |
| None |
Unchecked |
IC50 |
1.9 |
nM |
10.1021/jm9906015 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmcl.2009.12.047 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1021/jm800197b |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio.147 |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
0.19 |
None |
10.1021/jm100398z |
| None |
Unchecked |
Ratio IC50 |
0.5 |
None |
10.1021/np970343j |
| None |
Unchecked |
Ratio IC50 |
0.5 |
None |
10.1021/np980088i |
| None |
Unchecked |
Ratio IC50 |
59.0 |
None |
10.1016/j.bmc.2007.11.033 |
| None |
Unchecked |
Ratio IC50 |
96.81 |
None |
10.1016/j.bmc.2015.03.049 |
| None |
Unchecked |
Ratio IC50 |
101.52 |
None |
10.1016/j.ejmech.2014.03.001 |
| None |
Unchecked |
Ratio IC50 |
122.0 |
None |
10.1016/j.bmcl.2014.02.074 |
| None |
Unchecked |
Ratio IC50 |
205.4 |
None |
10.1016/j.ejmech.2012.08.046 |
| None |
Unchecked |
Selectivity |
410.0 |
None |
10.1016/s0960-894x(98)00717-3 |